Your browser does not allow JavaScript!
JavaScript is necessary for the proper functioning of this website. Please enable JavaScript or use a modern browser.
Repository of the University of Ljubljana
Open Science Slovenia
Open Science
DiKUL
slv
|
eng
Search
Advanced
New in RUL
About RUL
In numbers
Help
Sign in
Details
Lipophilic cations as mitochondria-targeting moieties : recent progress and design principles for medicinal chemistry
ID
Džajić, Ivan
(
Author
),
ID
Tomašič, Tihomir
(
Author
),
ID
Pardo A., Luis
(
Author
),
ID
Peterlin-Mašič, Lucija
(
Author
),
ID
Cotman, Andrej Emanuel
(
Author
)
PDF - Presentation file,
Download
(6,02 MB)
MD5: 092830EF1E8EAB49D18D2499D87A6CFB
URL - Source URL, Visit
https://pubs.acs.org/doi/10.1021/acs.jmedchem.5c02076
Image galllery
Abstract
Mitochondria-targeting technology, in the form of (lipophilic cation)–(small molecule) conjugates, was first discussed more than 50 years ago. Since then, the triphenylphosphonium (TPP) cation has become synonymous with the concept of a mitochondria-targeting moiety (MTM). The discovery of its ability to accumulate in mitochondria occurred alongside research on mitochondrial functions and the mechanisms underlying cation import. The recognition of intrinsic biological effects of TPP, apart from delivery of functional cargo, came much later, prompting the development of novel MTMs beyond the archetypal TPP. In this Perspective, we present the current understanding of the biological mechanisms of action of mitochondria-targeting conjugates, describe the methods used for their validation, and overview the recently developed novel mitochondria-targeting moieties. Building upon the recent advances, we propose a rational approach for the development of novel MTMs to be incorporated into the future MTM–linker–cargo therapeutics (MITACs, MITochondria-TArgeting Conjugates).
Language:
English
Keywords:
assays
,
cations
,
conjugate acid-base pairs
,
mitochondria
,
sensor probes
Work type:
Article
Typology:
1.02 - Review Article
Organization:
FFA - Faculty of Pharmacy
Publication status:
Published
Publication version:
Version of Record
Year:
2025
Number of pages:
Str. 23690−23704
Numbering:
Vol. 68, iss. 22
PID:
20.500.12556/RUL-177231
UDC:
543.2/.9
ISSN on article:
1520-4804
DOI:
10.1021/acs.jmedchem.5c02076
COBISS.SI-ID:
261779971
Publication date in RUL:
18.12.2025
Views:
654
Downloads:
292
Metadata:
Cite this work
Plain text
BibTeX
EndNote XML
EndNote/Refer
RIS
ABNT
ACM Ref
AMA
APA
Chicago 17th Author-Date
Harvard
IEEE
ISO 690
MLA
Vancouver
:
Copy citation
Share:
Record is a part of a journal
Title:
Journal of medicinal chemistry
Shortened title:
J. med. chem.
Publisher:
American Chemical Society
ISSN:
1520-4804
COBISS.SI-ID:
512806681
Licences
License:
CC BY 4.0, Creative Commons Attribution 4.0 International
Link:
http://creativecommons.org/licenses/by/4.0/
Description:
This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.
Secondary language
Language:
Slovenian
Keywords:
analize
,
kationi
,
konjugirani kislinsko-bazni par
,
mitohondriji
,
senzorske sonde
,
farmacevtska kemija
,
klinična kemija
Projects
Funder:
ARIS - Slovenian Research and Innovation Agency
Project number:
P1-0208
Name:
Farmacevtska kemija: načrtovanje, sinteza in vrednotenje učinkovin
Funder:
ARIS - Slovenian Research and Innovation Agency
Project number:
J7-4635
Name:
MitoCan - predklinični razvoj novih zaviralcev mitohondrijskih ionskih kanalov za zdravljenje raka
Funder:
University of Ljubljana
Funding programme:
Start-up
Project number:
SN-ZRD/22-27/510
Similar documents
Similar works from RUL:
Similar works from other Slovenian collections:
Back